Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica
Session 1. Deep dive into the WHO Strategic Directions for IPC: Political commitment and policies and active IPC programmes16 October 2022, 2:00-3:30 pm CETThe Global Strategy on Infection Prevention and Control (GSIPC) represents a turning point in the history of IPC with a clear vision and objectives to protect those accessing and providing care from associated infections by 2030. It also provides Member States with eight strategic directions (SD) to achieve measurable improvements and to substantially reduce the ongoing risk of health care-associated infections including those prone to epidemics and pandemics and those exhibiting antimicrobial resistance.The WHO IPC Hub Unit at WHO headquarters is organizing a special series of webinars to discuss the GSIPC key elements and implementation. In the first session of this four-part series, a panel of IPC specialists from global, national and facility levels will discuss how Strategic Directions “Political commitment and policies”
This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t
This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te
This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care u